Back to Search Start Over

Toll-like receptor (TLR)-9 genetics and function in sarcoidosis.

Authors :
Veltkamp M
Van Moorsel CH
Rijkers GT
Ruven HJ
Van Den Bosch JM
Grutters JC
Source :
Clinical and experimental immunology [Clin Exp Immunol] 2010 Oct; Vol. 162 (1), pp. 68-74. Date of Electronic Publication: 2010 Aug 19.
Publication Year :
2010

Abstract

Sarcoidosis is a systemic disorder characterized by the formation of non-caseating granulomas in variable organs. Toll-like receptor (TLR)-9 is important in the innate immune response against both Mycobacterium tuberculosis and Propionibacterium acnes, candidate causative agents in sarcoidosis. The aim of our study was to investigate possible genetic and functional differences in TLR-9 between patients and controls. TLR-9 single nucleotide polymorphisms were genotyped in 533 patients and divided into a study cohort and validation cohort and 185 healthy controls. Furthermore, part of the promotor as well as the entire coding region of the TLR-9 gene were sequenced in 20 patients in order to detect new mutations. No genetic differences were found between patients and controls. In order to test TLR-9 function, peripheral blood mononuclear cells (PBMCs) of 12 healthy controls and 12 sarcoidosis patients were stimulated with a TLR-9 agonist and the induction of interleukin (IL)-6, interferon (IFN)-γ and IL-23 was measured. Sarcoidosis patients produce significantly less IFN-γ upon stimulation with different stimuli. Regarding IL-23 production, a significant difference between patients and controls was found only after stimulation with the TLR-9 agonist. In conclusion, we did not find genetic differences in the TLR-9 gene between sarcoidosis patients and controls. Sarcoidosis patients produce less IFN-γ regardless of the stimulating agent, probably reflecting the anergic state often seen in their peripheral blood T lymphocytes. The differences in TLR-9-induced IL-23 production could indicate that functional defects in the TLR-9 pathway of sarcoidosis patients play a role in disease susceptibility or evolution.<br /> (© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.)

Details

Language :
English
ISSN :
1365-2249
Volume :
162
Issue :
1
Database :
MEDLINE
Journal :
Clinical and experimental immunology
Publication Type :
Academic Journal
Accession number :
20659127
Full Text :
https://doi.org/10.1111/j.1365-2249.2010.04205.x